Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients
- 1 December 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medical Care
- Vol. 47 (12), 1229-1236
- https://doi.org/10.1097/mlr.0b013e3181b58a85
Abstract
Race disparities in adjuvant chemotherapy for stage III colon cancer patients have been documented, and medical oncologist evaluation is a critical step in the treatment process. Recent healthcare system and environmental changes may have reduced treatment gaps. To examine differential rates of oncologist evaluation and conditional treatment, by race, and to determine whether changing evaluation and treatment patterns reduced disparities. Retrospective analysis of Surveillance Epidemiology and End Results-Medicare registry, enrollment, and claims data. Patients age >65, white or African American race, diagnosed with American Joint Committee on Cancer stage III colon cancer between 1997 and 2002. N = 7176. Oncology specialty evaluation and management visit or chemotherapy claim; receipt of 5-fluorouracil based chemotherapy. Time periods are grouped into early (1997-1998), middle (1999-2000), and late (2001-2002). Initial adjusted oncologist evaluation rates were higher for whites compared with African American patients (58.7% vs. 42.9%), but changes over time reduced the race gap substantially. We did not find significant race-time trends in treatment rates conditional on oncologist evaluation. Race disparities in medical oncologist evaluations diminished over time, possibly in response to increased provider supply or changing patient and provider attitudes, but there was no parallel reduction in disparities in conditional treatment rates. Projected decreases in oncologist supply suggest the need for further research on this relationship. Research on the role of supplemental medical insurance on disparities in treatment is needed, particularly as the cost of recommended adjuvant therapy increases.Keywords
This publication has 30 references indexed in Scilit:
- Racial disparities in cancer therapyCancer, 2008
- Advancing Health Disparities Research Within the Health Care System: A Conceptual FrameworkAmerican Journal of Public Health, 2006
- Referral to Medical Oncology: A Crucial Step in the Treatment of Older Patients with Stage III Colon CancerThe Oncologist, 2006
- Completion of Therapy by Medicare Patients With Stage III Colon CancerJNCI Journal of the National Cancer Institute, 2006
- Adjuvant Chemotherapy for Stage III Colon CancerJama-Journal Of The American Medical Association, 2005
- Explaining Black–White Differences in Receipt of Recommended Colon Cancer TreatmentJNCI Journal of the National Cancer Institute, 2005
- Use of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based CohortJournal of Clinical Oncology, 2003
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI Journal of the National Cancer Institute, 2002
- Adjuvant Therapy for Patients With Colon and Rectal CancerPublished by American Medical Association (AMA) ,1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990